#30585
Re: Farmas USA
Los más puestos explicad lo de AMRN, porque muy bueno no ha de ser.
http://seekingalpha.com/news-article/7004512-amarin-announces-public-offering-of-american-depositary-shares
Se está hablando de:
#30586
Re: Farmas USA
anda que ya se hace de rogar ... SNTA
POR CIERTO, PRO REAL TIME DICE QUE HA HECHO MAXIMOS EN 5,16 .... CREO QUE ES UN ERROR
#30587
Re: Farmas USA
A tomar por el culo....
4:52 PM Amarin (AMRN) announces a 21.7M share ADS offering, with a 30-day option to purchase an additional 3.255M ADSs. Citigroup and Jefferies are acting as joint book-runners.
$5.43 (-12%)
#30588
Re: Farmas USA
os iba a decir que teneis al Bastardo hablando de AMRN desde hace media hora :/
#30589
Re: Farmas USA
AMRN
Parece un 18% de dilución, ¿no? Estoy planteándome si saltar.
«Después de nada, o después de todo/ supe que todo no era más que nada.»
#30590
Re: Farmas USA
Si, pero yo no lo tengo nada claro...let's wait for the dust to settle.
#30591
Re: Farmas USA
BEDMINSTER, N.J. and DUBLIN, Ireland, July 8, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN) ("Amarin" or the "Company") today announced that it is offering to sell 21,700,000 American Depositary Shares ("ADSs") in an underwritten public offering. Amarin has also granted the underwriters a 30-day option to purchase an additional 3,255,000 ADSs.
Citigroup Global Markets Inc. and Jefferies LLC will act as joint book-running managers and underwriters in this offering, and propose to offer the ADSs at prevailing market prices or otherwise from time to time through the Nasdaq Global Market, the over-the-counter market, negotiated transactions or otherwise.
A registration statement relating to the ADSs described above was previously filed with and has become effective by rule of the Securities and Exchange Commission (the "SEC"). A preliminary prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC's website at http://www.sec.gov. Copies of the preliminary prospectus supplement and related prospectus, when available, may be obtained from Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, email: [email protected], telephone 1-800-831-9146; and Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 12th Floor, New York, New York, 10022, telephone: 877-547-6340, email: [email protected].
#30592
Re: Farmas USA
Sí, por lo menos ahora está bajando el rojo del after. -4,87% y mejorando. ¿Alguien tiene claro de qué va el tipo de acciones estas ADS?
«Después de nada, o después de todo/ supe que todo no era más que nada.»